Core Points - The company, Shandong Xinhua Medical Equipment Co., Ltd., announced a plan to repurchase and cancel 33,400 restricted shares due to certain incentive recipients no longer meeting the conditions [1][2] - The repurchase price is set at 7.55 yuan per share, totaling approximately 253,000 yuan [1][5] Summary by Sections Repurchase Cancellation Reason - The repurchase involves six incentive recipients, four of whom have changed jobs and two have retired, thus not meeting the conditions of the 2021 Restricted Stock Incentive Plan [2] Repurchase Quantity - The initial number of shares to be repurchased was 25,670, which was adjusted to 33,400 shares due to a capital reserve increase implemented in 2023 [3] Repurchase Price - The initial grant price was 11.26 yuan per share, which was adjusted to 7.55 yuan per share after multiple dividend distributions since 2021 [4] Funding Source and Amount - The repurchase will be funded by the company's own funds, with a total estimated amount of approximately 253,000 yuan [5] Decision Process - The company has completed necessary approvals and disclosures, with the board and supervisory committee approving the repurchase on October 29, 2025 [6] Impact on the Company - The repurchase will result in a minor reduction of total shares, reflecting the company's commitment to strict execution of the incentive plan and maintaining a stable equity structure [7]
新华医疗拟回购注销3.34万股限制性股票 涉及金额约25.3万元